Methods for assessing inverse publication bias of adverse events

Xing Xing1, Chang Xu2, Fahad M Al Amer3

  • 1Department of Biostatistics, Johns Hopkins University, Maryland, MD, USA.

PubMed

Insights

Publication bias (PB) challenges medical research. This study introduces methods to assess inverse publication bias (IPB) in adverse event data, offering solutions for more accurate systematic reviews.

Area of Science:

  • Medical research methodology
  • Evidence synthesis
  • Biostatistics

Background:

  • Publication bias (PB) impacts systematic reviews, often suppressing non-significant findings.
  • Inverse publication bias (IPB) is emerging, particularly for adverse events, where similar safety profiles may be favored.
  • Existing PB methods may be misapplied to IPB, leading to erroneous conclusions.

Purpose of the Study:

  • To present accessible methods for assessing IPB in adverse event data.
  • To differentiate between classic PB and IPB.
  • To provide practical guidance for evidence synthesis.

Main Methods:

  • Visual assessment using contour-enhanced funnel plots adapted for adverse events.
  • Quantitative analysis with Egger's regression test, Peters' regression test, and the trim-and-fill method.
  • Illustrative examples with statistical code for real-world scenarios.

Main Results:

  • Demonstration of tailored methods for IPB assessment in adverse events.
  • Comparison of visual and quantitative techniques for detecting bias.
  • Real-world examples highlighting IPB in different contexts.

Conclusions:

  • Accessible methods are provided to address IPB in systematic reviews of adverse events.
  • Accurate assessment of IPB is crucial to avoid misinterpretation of safety data.
  • The study offers valuable insights for researchers conducting evidence synthesis on adverse events.

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Bias01:22

Bias

Bias refers to any tendency that prevents a question from being considered unprejudiced. In research, bias occurs when one outcome or answer is selected or encouraged over others in sampling or testing. Bias can occur during any research phase, including study design, data collection, analysis, and publication.
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
4.1K
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
88
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
216
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
107
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
168